New feline herpes virus vaccine
AssigneeBoehringer Ingelheim Vetmedica GmbH
InventorsCallie Ann Visek, Robert Barry Mandell, Teshome Mebatsion, Ramesh Koukuntla, Eric Martin Vaughn
Life of this patent
Estimating the term…
Abstract
The present invention relates i.a. to an EHV (Equine Herpesvirus) comprising a Feline Herpes Virus (FHV) Antigen encoding sequence inserted into ORF70 (US4) and/or ORF1/3. Furthermore, the present invention relates to methods for immunizing a feline comprising administering to such feline an immunogenic composition of the present invention. Moreover, the present invention relates to methods for the treatment or prophylaxis of clinical signs caused by Feline Herpes Virus in a feline.
Claims19
An EHV (Equine Herpesvirus) comprising a Feline Herpes Virus (FHV) Antigen encoding sequence inserted into ORF70 (US4) and/or ORF1/3.
An EHV (Equine Herpesvirus) comprising one single Feline Herpes Virus (FHV) Antigen encoding sequence inserted into ORF70 (US4) and/or one single Feline Herpes Virus (FHV) Antigen encoding sequence inserted into ORF1/3.
Dependencies are inferred from the claim text.